speb/financial-data huggingface dataset:
INDP income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -5228919.00
INDP cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -5000.00
INDP balance_sheet (quarterly, 2025-06-30) — Net PPE: 33577.00
INDP balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -1673356.00
INDP balance_sheet (quarterly, 2025-06-30) — Non Current Prepaid Assets: 392572.00
INDP income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -4456763.00
INDP income_statement (quarterly, 2025-06-30) — Normalized Income: -5228919.00
INDP cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4018189.00
INDP income_statement (quarterly, 2025-06-30) — Operating Income: -4456763.00
INDP income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
INDP balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 604963.00
INDP balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 6502503.00
INDP income_statement (quarterly, 2025-06-30) — Other Gand A: 2289649.00
INDP income_statement (quarterly, 2025-06-30) — Other Income Expense: -772156.00
INDP income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -772156.00
INDP balance_sheet (quarterly, 2025-06-30) — Other Properties: 33577.00
INDP balance_sheet (quarterly, 2025-06-30) — Payables: 618515.00
INDP balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1889800.00
INDP balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 85887.00
INDP balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
INDP balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 255357.00
INDP income_statement (quarterly, 2025-06-30) — Pretax Income: -5228919.00
INDP income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 0.00
INDP income_statement (quarterly, 2025-06-30) — Research And Development: 2167114.00
INDP balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -70200532.00
INDP income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2289649.00
INDP balance_sheet (quarterly, 2025-06-30) — Share Issued: 604963.00
INDP cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 180763.00
INDP balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -1673356.00
INDP balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -1673356.00
INDP income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INDP income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Assets: 6839207.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -1673356.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Debt: 6536876.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -1673356.00
INDP income_statement (quarterly, 2025-06-30) — Total Expenses: 4456763.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 8512563.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 426149.00
INDP balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
INDP income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4456763.00
INDP balance_sheet (quarterly, 2025-06-30) — Working Capital: -2099505.00
INDP income_statement (quarterly, 2025-09-30) — +Operating Expense: 2648487.00
INDP income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
INDP balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 707420.00
INDP balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 77764956.00
INDP income_statement (quarterly, 2025-09-30) — Basic Average Shares: 997038.00
INDP income_statement (quarterly, 2025-09-30) — Basic EPS: -2.98
INDP cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 6157701.00
INDP balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 8686.00
INDP balance_sheet (quarterly, 2025-09-30) — Capital Stock: 16420.00
INDP balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 5825639.00
INDP balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 5825639.00
INDP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2235365.00
INDP cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2567427.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 249952.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -597.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Payable: 249952.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 249952.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -357997.00
INDP cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -108642.00
INDP cash_flow (quarterly, 2025-09-30) — Changes In Cash: -332062.00
INDP balance_sheet (quarterly, 2025-09-30) — Common Stock: 16420.00
INDP balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 4605727.00
INDP cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 2339169.00
INDP balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1440730.00
INDP balance_sheet (quarterly, 2025-09-30) — Current Assets: 6438993.00
INDP balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 8686.00
INDP balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 8686.00
INDP balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2234325.00
INDP cash_flow (quarterly, 2025-09-30) — Depreciation: 0.00
INDP cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 0.00
INDP cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 0.00
INDP income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 997038.00
INDP income_statement (quarterly, 2025-09-30) — Diluted EPS: -2.98
INDP income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — EBIT: -2648487.00
INDP income_statement (quarterly, 2025-09-30) — EBITDA: -2648487.00
INDP cash_flow (quarterly, 2025-09-30) — End Cash Position: 5825639.00
INDP cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2235365.00
INDP cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2567427.00
INDP income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1130764.00
INDP balance_sheet (quarterly, 2025-09-30) — Gross PPE: 8487.00
INDP balance_sheet (quarterly, 2025-09-30) — Invested Capital: 4605727.00
INDP cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 2339169.00
INDP cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
INDP cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 2339169.00
INDP income_statement (quarterly, 2025-09-30) — Net Income: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2975117.00
INDP cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2975117.00
INDP cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
INDP cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -103958.00
INDP balance_sheet (quarterly, 2025-09-30) — Net PPE: 8487.00
INDP cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 0.00
INDP balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 4605727.00
INDP balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 392572.00
INDP income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2648487.00
INDP income_statement (quarterly, 2025-09-30) — Normalized Income: -2975117.00
INDP cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2567427.00
INDP income_statement (quarterly, 2025-09-30) — Operating Income: -2648487.00
INDP income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
INDP balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1641920.00
INDP income_statement (quarterly, 2025-09-30) — Other Gand A: 1130764.00
INDP income_statement (quarterly, 2025-09-30) — Other Income Expense: -326630.00
INDP income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -326630.00
INDP balance_sheet (quarterly, 2025-09-30) — Other Properties: 8487.00
INDP balance_sheet (quarterly, 2025-09-30) — Payables: 741520.00
INDP balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2182250.00
INDP balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 43389.00
INDP balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
INDP balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 613354.00
INDP income_statement (quarterly, 2025-09-30) — Pretax Income: -2975117.00
INDP income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
INDP income_statement (quarterly, 2025-09-30) — Research And Development: 1517723.00
INDP balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -73175649.00
INDP income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1130764.00
INDP balance_sheet (quarterly, 2025-09-30) — Share Issued: 1641920.00
INDP cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
INDP cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 150614.00
INDP balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 4605727.00
INDP balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 4605727.00
INDP income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INDP income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Assets: 6840052.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 4605727.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Debt: 8686.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 4605727.00
INDP income_statement (quarterly, 2025-09-30) — Total Expenses: 2648487.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2234325.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 401059.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
INDP income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2648487.00
INDP balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 34100.00
INDP balance_sheet (quarterly, 2025-09-30) — Working Capital: 4204668.00
INDP income_statement (annual, 2025-12-31) — +Operating Expense: 19833513.00
INDP income_statement (quarterly, 2025-12-31) — +Operating Expense: 8155704.00
INDP income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
INDP income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
INDP balance_sheet (annual, 2025-12-31) — Accounts Payable: 544057.00
INDP balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 544057.00
INDP balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 84408018.00
INDP balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 84408018.00
INDP income_statement (annual, 2025-12-31) — Basic Average Shares: 966124.00
INDP income_statement (annual, 2025-12-31) — Basic EPS: -21.58
INDP cash_flow (annual, 2025-12-31) — Beginning Cash Position: 5786753.00
INDP cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 5825639.00
INDP balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 0.00
INDP balance_sheet (annual, 2025-12-31) — Capital Stock: 31674.00
INDP balance_sheet (quarterly, 2025-12-31) — Capital Stock: 31674.00
INDP balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8507628.00
INDP balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8507628.00
INDP balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8507628.00
INDP balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8507628.00
INDP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 17544131.00
INDP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5872502.00
INDP cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -14823256.00
INDP cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -3190513.00
INDP cash_flow (annual, 2025-12-31) — Change In Account Payable: 2848858.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 3932936.00
INDP cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1989.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -199.00
INDP cash_flow (annual, 2025-12-31) — Change In Payable: 2848858.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Payable: 3932936.00
INDP cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2848858.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3932936.00
INDP cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 667288.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 203386.00
INDP cash_flow (annual, 2025-12-31) — Change In Working Capital: 3514157.00
INDP cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 4136123.00
INDP cash_flow (annual, 2025-12-31) — Changes In Cash: 2720875.00
INDP cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2681989.00
INDP balance_sheet (annual, 2025-12-31) — Common Stock: 21674.00
INDP balance_sheet (quarterly, 2025-12-31) — Common Stock: 21674.00
INDP balance_sheet (annual, 2025-12-31) — Common Stock Equity: 3141593.00
INDP balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 3141593.00
INDP cash_flow (annual, 2025-12-31) — Common Stock Issuance: 6396888.00
INDP cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
INDP balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 1505077.00
INDP balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 1505077.00
INDP balance_sheet (annual, 2025-12-31) — Current Assets: 9310168.00
INDP balance_sheet (quarterly, 2025-12-31) — Current Assets: 9310168.00
INDP balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 0.00
INDP balance_sheet (annual, 2025-12-31) — Current Liabilities: 6158575.00
INDP balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 6158575.00
INDP cash_flow (annual, 2025-12-31) — Depreciation: 0.00
INDP cash_flow (quarterly, 2025-12-31) — Depreciation: 0.00
INDP cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 0.00
INDP cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 0.00
INDP cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 0.00
INDP cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 0.00
INDP income_statement (annual, 2025-12-31) — Diluted Average Shares: 966124.00
INDP income_statement (annual, 2025-12-31) — Diluted EPS: -21.58
INDP income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -8112450.00
INDP income_statement (annual, 2025-12-31) — EBIT: -19833513.00
INDP income_statement (quarterly, 2025-12-31) — EBIT: -8155704.00
INDP income_statement (annual, 2025-12-31) — EBITDA: -19833513.00
INDP income_statement (quarterly, 2025-12-31) — EBITDA: -8155704.00
INDP cash_flow (annual, 2025-12-31) — End Cash Position: 8507628.00
INDP cash_flow (quarterly, 2025-12-31) — End Cash Position: 8507628.00
INDP cash_flow (annual, 2025-12-31) — Financing Cash Flow: 17544131.00
INDP cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5872502.00
INDP cash_flow (annual, 2025-12-31) — Free Cash Flow: -14823256.00
INDP cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -3190513.00
INDP income_statement (annual, 2025-12-31) — General And Administrative Expense: 10492554.00
INDP income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5310422.00
INDP balance_sheet (annual, 2025-12-31) — Gross PPE: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Gross PPE: 0.00
INDP balance_sheet (annual, 2025-12-31) — Invested Capital: 3141593.00
INDP balance_sheet (quarterly, 2025-12-31) — Invested Capital: 3141593.00
INDP cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 12396888.00
INDP cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 6000000.00
INDP cash_flow (annual, 2025-12-31) — Issuance Of Debt: 5714800.00
INDP cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
INDP cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 5714800.00
INDP cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 6396888.00
INDP cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
INDP income_statement (annual, 2025-12-31) — Net Income: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income: -8112450.00
INDP income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -8112450.00
INDP income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -8112450.00
INDP income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8112450.00
INDP income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -8112450.00
INDP cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -20848916.00
INDP cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -8112450.00
INDP income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -8112450.00
INDP cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 5714800.00
INDP cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
INDP cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 5714800.00
INDP cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -569465.00
INDP cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -129252.00
INDP balance_sheet (annual, 2025-12-31) — Net PPE: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Net PPE: 0.00
INDP cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 6000000.00
INDP balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3151593.00
INDP balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3151593.00
INDP balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 0.00
INDP income_statement (annual, 2025-12-31) — Normalized EBITDA: -19833513.00
INDP income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -8155704.00
INDP income_statement (annual, 2025-12-31) — Normalized Income: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Normalized Income: -8112450.00
INDP cash_flow (annual, 2025-12-31) — Operating Cash Flow: -14823256.00
INDP cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -3190513.00
INDP income_statement (annual, 2025-12-31) — Operating Income: -19833513.00
INDP income_statement (quarterly, 2025-12-31) — Operating Income: -8155704.00
INDP income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
INDP income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
INDP balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2167324.00
INDP balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2167324.00
INDP income_statement (annual, 2025-12-31) — Other Gand A: 10492554.00
INDP income_statement (quarterly, 2025-12-31) — Other Gand A: 5310422.00
INDP income_statement (annual, 2025-12-31) — Other Income Expense: -1015403.00
INDP income_statement (quarterly, 2025-12-31) — Other Income Expense: 43254.00
INDP income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1015403.00
INDP income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 43254.00
INDP balance_sheet (annual, 2025-12-31) — Payables: 628157.00
INDP balance_sheet (quarterly, 2025-12-31) — Payables: 628157.00
INDP balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2133234.00
INDP balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2133234.00
INDP balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4025341.00
INDP balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4025341.00
INDP balance_sheet (annual, 2025-12-31) — Preferred Stock: 10000.00
INDP balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 10000.00
INDP balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 10000.00
INDP balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 10000.00
INDP cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 6000000.00
INDP balance_sheet (annual, 2025-12-31) — Prepaid Assets: 802540.00
INDP balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 802540.00
INDP income_statement (annual, 2025-12-31) — Pretax Income: -20848916.00
INDP income_statement (quarterly, 2025-12-31) — Pretax Income: -8112450.00
INDP cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 1908.00
INDP cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1754.00
INDP income_statement (annual, 2025-12-31) — Reconciled Depreciation: 0.00
INDP income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 0.00
INDP income_statement (annual, 2025-12-31) — Research And Development: 9340959.00
INDP income_statement (quarterly, 2025-12-31) — Research And Development: 2845282.00
INDP balance_sheet (annual, 2025-12-31) — Retained Earnings: -81288099.00
INDP balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -81288099.00
INDP income_statement (annual, 2025-12-31) — Selling General And Administration: 10492554.00
INDP income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5310422.00
INDP balance_sheet (annual, 2025-12-31) — Share Issued: 2167324.00
INDP balance_sheet (quarterly, 2025-12-31) — Share Issued: 2167324.00
INDP cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1358082.00
INDP cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 785814.00
INDP balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3151593.00
INDP balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3151593.00
INDP balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3141593.00
INDP balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3141593.00
INDP income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INDP income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INDP income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
INDP income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
INDP balance_sheet (annual, 2025-12-31) — Total Assets: 9310168.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Assets: 9310168.00
INDP balance_sheet (annual, 2025-12-31) — Total Capitalization: 3151593.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3151593.00
INDP balance_sheet (annual, 2025-12-31) — Total Debt: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Debt: 0.00
INDP balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3151593.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3151593.00
INDP income_statement (annual, 2025-12-31) — Total Expenses: 19833513.00
INDP income_statement (quarterly, 2025-12-31) — Total Expenses: 8155704.00
INDP balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 6158575.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 6158575.00
INDP balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 0.00
INDP balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
INDP income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -19833513.00
INDP income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -8155704.00
INDP balance_sheet (annual, 2025-12-31) — Total Tax Payable: 84100.00
INDP balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 84100.00
INDP cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1153421.00
INDP cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
INDP balance_sheet (annual, 2025-12-31) — Working Capital: 3151593.00
INDP balance_sheet (quarterly, 2025-12-31) — Working Capital: 3151593.00
INDP income_statement (quarterly, 2026-03-31) — +Operating Expense: 2159588.00
INDP income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 557367.00
INDP balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 83944602.00
INDP income_statement (quarterly, 2026-03-31) — Basic Average Shares: 10956650.00
INDP income_statement (quarterly, 2026-03-31) — Basic EPS: -0.23
INDP cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 8507628.00
INDP balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1132424.00
INDP balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1497635.00
INDP balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1497635.00
INDP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
INDP cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -7009993.00
INDP cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -5225576.00
INDP cash_flow (quarterly, 2026-03-31) — Change In Payable: -5225576.00
INDP cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -5225576.00
INDP cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 119319.00
INDP cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5106257.00
INDP cash_flow (quarterly, 2026-03-31) — Changes In Cash: -7009993.00
INDP balance_sheet (quarterly, 2026-03-31) — Common Stock: 1132424.00
INDP balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1247857.00
INDP cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 330257.00
INDP balance_sheet (quarterly, 2026-03-31) — Current Assets: 2180856.00
INDP balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 932999.00
INDP income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 10956650.00
INDP income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.23
INDP income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — EBIT: -2159588.00
INDP income_statement (quarterly, 2026-03-31) — EBITDA: -2159588.00
INDP cash_flow (quarterly, 2026-03-31) — End Cash Position: 1497635.00
INDP cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
INDP cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -7009993.00
INDP income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 1668454.00
INDP balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1247857.00
INDP cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
INDP cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
INDP income_statement (quarterly, 2026-03-31) — Net Income: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -2541070.00
INDP cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -2541070.00
INDP balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1247857.00
INDP income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -2159588.00
INDP income_statement (quarterly, 2026-03-31) — Normalized Income: -2541070.00
INDP cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -7009993.00
INDP income_statement (quarterly, 2026-03-31) — Operating Income: -2159588.00
INDP income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 113242324.00
INDP income_statement (quarterly, 2026-03-31) — Other Gand A: 1668454.00
INDP income_statement (quarterly, 2026-03-31) — Other Income Expense: -381482.00
INDP cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 410154.00
INDP income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -381482.00
INDP balance_sheet (quarterly, 2026-03-31) — Payables: 559667.00
INDP balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 889924.00
INDP balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 43075.00
INDP balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 683221.00
INDP income_statement (quarterly, 2026-03-31) — Pretax Income: -2541070.00
INDP income_statement (quarterly, 2026-03-31) — Research And Development: 491134.00
INDP balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -83829169.00
INDP income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1668454.00
INDP balance_sheet (quarterly, 2026-03-31) — Share Issued: 113242324.00
INDP cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 227180.00
INDP balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1247857.00
INDP balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1247857.00
INDP income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INDP income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Assets: 2180856.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1247857.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1247857.00
INDP income_statement (quarterly, 2026-03-31) — Total Expenses: 2159588.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 932999.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 0.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
INDP income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -2159588.00
INDP balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 2300.00
INDP balance_sheet (quarterly, 2026-03-31) — Working Capital: 1247857.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1865300000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -79300000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 230100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 2013400000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 404400000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 13000000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 13200000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 68600000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 512800000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Interest Income: 31200000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 31200000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 658600000.00
INDRAMEDCO.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -471100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 153100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 34400000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 17100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 6100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 17900000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Other Payable: 7300000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Other Special Charges: 57700000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8700000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 94100000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 93800000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 18600000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 18600000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 24400000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1958300000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 533500000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 602100000.00
INDRAMEDCO.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 28000000.00
INDRAMEDCO.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2323500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — +Total Revenue: 10649500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 981800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 682400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -2158600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -85300000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Amortization: 14300000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 474200000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 91673000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Basic EPS: 9.40
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 417400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 2044800000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -445800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 24800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 916700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 522600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 1329900000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -228400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 512300000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 10300000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 15400000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Change In Payable: 286100000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -234900000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 66600000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 105200000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Common Stock: 916700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3794500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 72100000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 7203000000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2230800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 24800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 24800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1296300000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 94900000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Depreciation: 392700000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 392700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 392700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 378400000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 91673000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Diluted EPS: 9.40
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 861500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 14000000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — EBIT: 1176400000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — EBITDA: 1569100000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — End Cash Position: 522600000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -260400000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 998900000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 8700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 96900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 9600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 767700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 4971600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Gross Profit: 3446500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Interest Expense: 4600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 4600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Interest Income: 100300000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 100300000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -3700000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Interest Paid Cfo: -900000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 89400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Inventory: 84500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 3794500000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -1079100000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 474200000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 244200000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 760200000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income: 861500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 861500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 861500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 861500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 861500000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1171800000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 861500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Interest Income: 57500000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -722700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 57500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2813000000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -445800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 3784900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 199800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 244200000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 23800000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 1577800000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Normalized Income: 867896185.36
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 1444700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Operating Income: 1123000000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Operating Revenue: 10649500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 91673000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 108600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 59600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 2877800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 9600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 3700000.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -95700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 70600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 16600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 100300000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 1252900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Payable: 7600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2094500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 807300000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Other Special Charges: 8700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Payables: 1047600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 94900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 108600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Pretax Income: 1171800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -445800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 80800000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 7203000000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 392700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 21900000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 21900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 25400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2590600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 872700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 969600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Share Issued: 91673000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Special Income Charges: -8700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 3794500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 3784900000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -2303814.64
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Tax Provision: 310300000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.26
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
INDRAMEDCO.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -98500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Assets: 5551400000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 3794500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Debt: 24800000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 3794500000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Total Expenses: 9526500000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 1756900000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3320600000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 460600000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 38200000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 44200000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -8700000.00
INDRAMEDCO.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -8700000.00
INDRAMEDCO.NS balance_sheet (annual, 2023-03-31) — Working Capital: 934500000.00
INDRAMEDCO.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2590200000.00
INDRAMEDCO.NS income_statement (annual, 2024-03-31) — +Total Revenue: 12040600000.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1328900000.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 584000000.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -2128400000.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -103100000.00
INDRAMEDCO.NS income_statement (annual, 2024-03-31) — Amortization: 6200000.00
INDRAMEDCO.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 605200000.00
INDRAMEDCO.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 91673000.00
INDRAMEDCO.NS income_statement (annual, 2024-03-31) — Basic EPS: 13.52